The United States is seeing rapid development of state-legal cannabis companies, and this has caught the attention of many investors seeking to capitalize on the growth of legal cannabis. Ben Ward, CEO of Canadian licensed producer Maricann Group (CSE: MARI) is optimistic about the developing market in the U.S., but he sees opportunity beyond the United States and Canada, especially in Europe.
In a contribution to CNBC, Ward suggested that there is a “global revolution” underway and points to the European Union’s much larger population as a reason to pay attention. He highlights Germany’s new medical cannabis program, which features health insurance coverage and pharmacy distribution as reasons Maricann is building up its European presence.
European markets are increasingly important to the cannabis sector. Each has a well-funded medical system, residents who seek natural and complementary therapies, and a government-supported mandate to stop the rising tide of opiate addiction related to chronic pain treatment.
Read Ben Ward’s “Forget the US. Here’s where medical marijuana is really taking off”: http://www.cnbc.com/2017/07/19/medical-marijuana-is-really-taking-off-in-europe-commentary.html
